R1 RCM, through its dedicated AI lab R37, applies artificial intelligence and automation to healthcare revenue cycle management. The company builds enterprise software to address administrative inefficiencies, delayed payments, and preventable claim denials that burden hospitals and health systems. Its technical work spans agentic AI, real-time adjudication, and large-scale automation.
The company's flagship product, the Phare platform, is described as healthcare's first Revenue Operating System. It uses agentic AI to enable real-time adjudication and align incentives between payers and providers. R37 Lab functions as a focused research and development unit, continuously developing new AI-driven solutions aimed at comprehensive automation of revenue cycle processes.
R1 operates primarily in the United States and partners with 95 of the top 100 US health systems. The company reports recovering over $6 billion in annual revenue for clients, automating more than 200 million tasks, and reducing the cost to collect by 50%. With two decades of operating experience, R1's platform has delivered yield improvements of 5-7% for its health system partners.
